Chris Maxted
Partner, expert in Pharmaceuticals and Life Sciences: Leading R&D, Quality & Compliance, and Commercial Transformation Across Global Pharma
Chris
"There are huge opportunities for companies that can think about patients more holistically, whether that’s in disease prevention, improved diagnosis, or monitoring and managing conditions. Technology and our understanding of the causes of disease are now at a stage where this vision can finally become a reality."
At a glance:
- 20+ years’ experience leading transformation across global Pharma and Life Sciences organisations.
- Expert in R&D, Quality & Compliance and GxP, including large‑scale QMS redesign and inspection‑readiness programmes.
- Commercial and Market Access transformation, supporting specialty product launches and global‑to‑local operating models.
- Collaborative, embedded working style, partnering directly with clients to navigate complexity and drive lasting organisational change.
In detail:
R&D and Clinical Operations Transformation
Chris supports global R&D functions to streamline clinical development processes, remove legacy complexity, and ensure that teams operate with clarity, accountability and confidence. His work includes redesigning end‑to‑end R&D operating models; simplifying governance frameworks; and reducing procedural overhead—such as consolidating thousands of legacy compliance documents into a small number of core, strategic processes.
These changes help clients meet regulatory expectations more consistently, free up capacity for innovation, and accelerate progress across the drug development lifecycle.
Quality & Compliance Leadership (GxP, QMS, Inspection Readiness)
A core part of Chris’s experience is modernising Quality and Compliance capabilities within global pharmaceutical organisations. He has led major QMS programmes spanning clinical operations, regulatory affairs, pharmacovigilance and medical functions—strengthening GxP compliance and improving operational performance.
He brings deep experience in designing risk‑based Quality systems, replacing document‑heavy legacy processes with streamlined digital workflows, and preparing organisations for inspection readiness at scale.
Digital Quality & Workflow Platforms
Chris has delivered multiple programmes using cloud‑based Quality platforms—including Veeva and Casewise—to improve consistency, auditability and cross‑functional alignment. These digital infrastructures help global teams work more efficiently, reduce operational risk, and maintain compliance across markets.
Commercial & Market Access Operating Models
Beyond R&D and Quality, Chris also supports commercial transformation—designing new operating models to enable specialty product launches and improve market access performance. His work helps organisations connect commercial strategy with day‑to‑day execution, ensuring teams are aligned, accountable and equipped to bring new treatments to market effectively.
Client‑embedded, people‑centred consulting style
Chris is known for his ability to embed directly into client organisations—working side‑by‑side with individuals and teams to understand not just the technical challenges, but the human motivations and pressures that shape them. He helps stakeholders see the bigger picture, offering strategic challenge and uncovering opportunities that deliver outsized value.
Thought leadership & industry insight
Chris contributes to Baringa’s insight and transformation work across the Pharma sector, including improving patient engagement, modernising omnichannel communication capabilities, and addressing health system and workforce challenges. His experience spans operational, clinical and commercial domains, giving him a broad perspective on how pharmaceutical organisations can deliver greater value across the product lifecycle.
Connect with Chris
To discuss how Chris can support your organisation across R&D transformation, Quality & Compliance, or commercial operating model design, please get in touch via the Baringa team.
Find out how Baringa helps pharmaceutical and life science businesses
Insights from Chris Maxted
Embracing change: ICH E6(R3) as a catalyst for innovation in clinical development
The pharmaceutical industry is entering a new chapter with the release of the updated ICH E6(R3) Good Clinical Practice guidelines.
Read more
Embracing patients as partners to unlock greater engagement and better science
By working in true partnership with patients, caregivers and advocacy groups, the quality of your science and the care patients receive will be improved, and satisfaction will be higher.
Read more
Tackling the disparities in clinical trial access for better health equity
Older people, women, those who are disabled or identify as LGBTQ+ and people from lower socioeconomic backgrounds and ethnically and racially diverse populations are all typically underrepresented in clinical trials. Discover how patient diversity can benefit your business, healthcare and patients themselves.
Read more
Delivering winning omnichannel experiences to customers on a global scale
How do we best design a global programme to upskill leadership in omnichannel communications and encourage an agile mindset?
Read moreIs digital and AI delivering what your business needs?
Digital and AI can solve your toughest challenges and elevate your business performance. But success isn’t always straightforward. Where can you unlock opportunity? And what does it take to set the foundation for lasting success?